Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
0.1725
+0.0212 (14.01%)
At close: May 12, 2025, 4:00 PM
0.1650
-0.0075 (-4.35%)
After-hours: May 12, 2025, 7:59 PM EDT
Vor Biopharma Employees
Vor Biopharma had 159 employees as of December 31, 2024. The number of employees decreased by 9 or -5.36% compared to the previous year.
Employees
159
Change (1Y)
-9
Growth (1Y)
-5.36%
Revenue / Employee
n/a
Profits / Employee
-$735,308
Market Cap
21.54M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 159 | -9 | -5.36% |
| Dec 31, 2023 | 168 | 35 | 26.32% |
| Dec 31, 2022 | 133 | -2 | -1.48% |
| Dec 31, 2021 | 135 | 47 | 53.41% |
| Dec 31, 2020 | 88 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VOR News
- 4 days ago - Vor Bio Announces Exploration of Strategic Alternatives to Maximize Shareholder Value - GlobeNewsWire
- 7 weeks ago - Vor Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 3 months ago - Vor Bio Presents Novel Research Highlighting Opportunities and Challenges Facing Institutions Enrolling Patients in Cell and Gene Therapy Trials - GlobeNewsWire
- 3 months ago - Vor Bio to Participate in the Oppenheimer's 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 4 months ago - Vor Bio Appoints Life Sciences and Technology Investor and Entrepreneur, Mr. Erez Kalir to its Board of Directors - GlobeNewsWire
- 4 months ago - Vor Bio Announces $55.6 Million Private Placement - GlobeNewsWire
- 5 months ago - Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design - GlobeNewsWire
- 8 months ago - Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer - GlobeNewsWire